Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Özet

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 31-JUN 04, 2019

Açıklama

Anahtar kelimeler

Alıntı

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By